Novartis Investigative Site

Cheboksary 428028

0 studies enrolling now · 5 studies all time

What they study most

Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Proliferative Diabetic Retinopathy, Retinopathy of Prematurity, Retinopathy of Prematurity (ROP)

Studies at this site

• Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy — Completed
• Rainbow Extension Study — Completed
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion — Stopped early
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion — Stopped early
• RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity — Completed